Finall Exam:l NRl 577/l NR577l (Latestl
2026/l 2027l Update)l Primaryl Carel Managementl ofl Adolescentsl andl Adultsl Guidel |Weeksl 5-8l Coveredl |Q/Al |l Gradel A|l 100%l Correctl (Verifiedl Answers)l - Chamberlain
Q:l Rapidl actingl insulin
Answer:
Humalog(l Lispro) Novalogl (Aspart) Apidra
Q:l Rapidl actingl insulin
Answer:
onsetl 5-30l minutesl durationl 3-4hrs
Q:l Shortl actingl insulin
Answer:
Regularl (Humulinl Rl orl Novalinl R)
Q:l Shortl actingl insulinl onset
Answer:
30-60l minutesl durationl 3-7hrs 1 / 4
Q:l Intermediatel actingl insulin
Answer:
NPHl orl Humulinl N
Q:l Longl actingl insulin
Answer:
Lantus,l levimir
Q:l Fixedl combinationl insulin
Answer:
NPH/Regl 70/30,l 50/50,l 75/25,l 70/30
Q:l Hypothyrodisiml andl skin
Answer:
Thickl coursel dryl skin
Q:l Hyperthryodisml andl skin
Answer:
smoothl silky
Q:l Whatl isl thel drugl ofl choicel forl DM2
Answer:
metformin
- / 4
Q:l MOAl ofl metformin
Answer:
enhancel tissuel responsivenessl tol insulin.l Theyl arel alsol lessl likelyl tol causel hypoglycemial andl helpl txl insulinl resistance.l Metforminl facilitatesl insulinl uptakel byl peripherall tissuel especiallyl musclel andl liverl andl decreasel hepaticl gluconeogenesisl andl basall glucosel outputl thusl loweringl fastingl glucosel levels.
Q:l Dosingl ofl metformin
Answer:
Startingl 500mgl QDl thenl afterl onel weekl 500mgl BIDl thenl increasel slowlyl overl 1-2l wksl beforel yourl atl maxl dosel betweenl 2000-2500mg/QD
Q:l Sulfonylureasl (Glyburide,l glipizide,l glimepridie)l MOA
Answer:
acutleyl increasel thel sensitivityl ofl betal cellsl tol gluocsel andl stimulatel endogenousl insulinl release.l Thisl canl leadl tol hypoglycemia
Q:l Dosingl ofl glyburide
Answer:
2.5mgl BID
Q:l dosingl ofl glipizide
Answer:
5mgl bID
Q:l dosingl ofl glimerpridie 3 / 4
Answer:
1mgl daily
Q:l Prandiall insulinl control
Answer:
isl controllingl insulinl beforel meals
Q:l Whatl isl thel somogyil phenomenon
Answer:
earlyl morningl hyperglycemial occursl duel tol al reboundl effectl froml late-nightl hypoglycemia
Q:l Howl tol recognizel somogyil phenomoneon
Answer:
nightl sweats,l poorl sleep,l nightmares,l morningl headaches.
Q:l Howl tol txl somogyil phenomoenon
Answer:
traill dosel ofl insulinl reductionl slowlyl orl ifl someonel isl onl NPHl switchl thel timingl froml eveningl dosel ofl NPHl tol bedtimel mayl resolvel thel nocturnall hypoglycemial issue.l Orl youl canl switchl NPHl tol insulinl glargine.
Q:l Thiazolidineodionesl MOA
Answer:
decreasingl insulinl resistancel inl peripherall tissuesl includingl fat,l musclel andl liverl thusl increasingl glucosel utilizationl andl decreasingl glucosel production.
- / 4